SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049119
Filing Date
2024-04-26
Accepted
2024-04-26 16:10:04
Documents
5
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A ubx-2024_def_14a.htm DEF 14A 981714
2 GRAPHIC img52149799_0.jpg GRAPHIC 146140
3 GRAPHIC img52149799_1.jpg GRAPHIC 151041
4 GRAPHIC img52149799_2.jpg GRAPHIC 113373
5 GRAPHIC img52149799_3.jpg GRAPHIC 90590
  Complete submission text file 0000950170-24-049119.txt   1673124
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38470 | Film No.: 24883745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)